Advances in Nuclear Cardiology - An Overview

Introduction

Nuclear cardiology is extensively utilized for diagnosing ischemic heart disease and cardiac failure, deciding on therapeutic approaches, evaluating therapy effects, and forecasting serious cardiac events. Nuclear cardiology relies mostly on two imaging modalities:

• Single photon emission computed tomography (SPECT).

• Positron emission tomography.

Hybrid imaging systems that combine single photon emission computed tomography and positron emission tomography with computed tomography (CT) are also often utilized, and hybrid magnetic resonance imaging (MRI) and PET systems have just been created. The development of these devices, as well as various imaging radiotracers, has benefitted the area of nuclear cardiology. Myocardial perfusion imaging (MPI) using ECG-gated SPECT is an effective imaging method for detecting coronary artery disease (CAD) and predicting prognosis. Conventional SPECT cameras, on the other hand, use sodium iodide (NaI) detectors and massive photomultiplier tubes (PMTs), resulting in suboptimal photon detection and processing, as well as degraded image quality.

What Is Nuclear Cardiology?

Nuclear cardiology is a subspecialty of general cardiology that uses radioactive chemicals and advanced medical imaging techniques to assess, diagnose, and treat cardiac diseases. Nuclear cardiologists must complete up to eight years of secondary education and a residency program before becoming certified by the Certification Board of Nuclear Cardiology (CBNC).

What Are the Advances in Nuclear Cardiology?

1. Development of Hardware: Traditional gamma-camera imaging for the perfusion of the myocardium has been conducted using Anger-type gamma cameras, which include scintillator detectors [thallium-doped sodium iodide, NaI(Tl)] as the gamma-photon an absorber, photomultiplier tubes for electric signal generation, and an Anger-logic computer for the mathematical identification of specific signals.

2. Development of Software: In software development, iterative rebuilding algorithms such as maximum-likelihood expectation maximization (MLEM) and ordered-subset expectation maximization (OSEM) are commonly utilized. Because ordered-subset expectation maximization requires less processing time than maximum-likelihood expectation maximization, it has become more common in modern gamma cameras. OSEM produces higher-quality myocardial perfusion SPECT pictures than standard filtered-back projection (FBP) reconstruction.

3. Trends in Myocardial Perfusion Agents: In nuclear cardiology, myocardial perfusion is assessed using radiopharmaceuticals with a high first-pass extraction percentage. If a radiopharmaceutical has a perfect first-pass extraction fraction, the blood flow determines its absorption degree rather than the extraction fraction. As a result, a high extraction fraction is required for effective myocardial perfusion agents.

4. Challenges of Myocardial Perfusion Imaging: As previously explained, SPECT and PET are used in nuclear cardiology to accomplish myocardial perfusion imaging. For decades, myocardial perfusion SPECT has been extensively studied for its diagnostic use in coronary artery disease. Myocardial perfusion SPECT's prognostic usefulness has also been widely explored and validated, providing excellent risk classification for coronary artery disease. CT was first utilized to assess coronary calcium accumulation, then coronary CT angiography, and finally, myocardial perfusion imaging. MRI is useful for determining myocardial scar tissue based on late-enhancement findings and gives excellent assessments of myocardial wall motion and ejection fraction.

5. F-18 Fluorodeoxyglucose (FDG) Myocardial PET for Myocardial Infarction: F-18 FDG is commonly used in oncology. In nuclear cardiology, F-18 FDG uptake is regarded as a biomarker of viable myocardium, and a perfusion or metabolism mismatch is indicative of ischemic viable myocardium that should be rescued via revascularization. To detect viable myocardium, glucose loading with/without intravenous insulin administration enhances F-18 FDG absorption in both normal and ischemic viable myocardium. Intravenous insulin injections can sometimes cause severe hypoglycemia. As a result, careful monitoring of the whole-blood glucose level via a finger-stick blood test and the administration of a 50 percent glucose solution is frequently required.

6. F-18 Sodium Fluoride (NaF) PET for Coronary Plaques: F-18 NaF was initially used as a bone-seeking agent, and bone PET using F-18 NaF has been frequently used to evaluate bone or joint pathologies. Although vascular calcification is positive for F-18 NaF-uptake, not all gross calcification seen in CT scans was positive for F-18 NaF uptake. In a recent electron microscopy investigation, microcalcification was proved to have a larger tendency for F-18 NaF uptake than macrocalcification. F-18 NaF PET is regarded to be useful for the evaluation of early vascular calcification or molecular calcification.

7. Restricted Heart Disease: The characteristics of restrictive heart disease are relatively maintained systolic function and the infiltration of cellular or subcellular components into the myocardium, which impairs diastolic relaxation. Imaging procedures such as echocardiography, cardiac CT, or MRI frequently reveal only non-specific abnormalities. Nuclear cardiology is primarily concerned with cardiac sarcoidosis and amyloidosis, among other disease causes. Cardiac sarcoidosis is an inflammatory illness characterized by pathological evidence of non-caseating granuloma infiltration of the heart. Sarcoidosis is a systemic illness, and heart involvement (also known as cardiac sarcoidosis) increases the chance of death. Because anti-inflammatory therapy with glucocorticoids is an effective therapeutic option, correct diagnosis of cardiac sarcoidosis is critical.

8. Cardiac Amyloidosis: Another intriguing limiting heart disease is cardiac amyloidosis. There are two kinds of cardiac amyloidosis: transthyretin (TTR) and light chain (AL). AL-type amyloidosis is thought to be a subsequent manifestation of a plasma cell-related systemic illness. The cardiac involvement of AL amyloidosis is associated with a bad prognosis.

What Is the Nuclear Cardiac Stress Test?

A nuclear cardiac test is used to diagnose cardiac disease. A tracer or radiopharmaceutical is a small amount of radioactive substance that a healthcare provider injects into the bloodstream. Blood arteries and heart muscle absorb the tracer, making them appear more prominent in photographs. The provider then uses a special camera to photograph blood flow in and around the heart. The test could alternatively be called:

• Cardiac positron emission tomography (PET).

• Cardiac SPECT (single photon emission computed tomography).

• Myocardial perfusion imaging (MPI).

• Nuclear stress tests.

What Are the Types of Nuclear Cardiac Stress Tests?

A nuclear cardiac stress test can be performed using PET or SPECT imaging technology.

A nuclear stress testcan also be characterized by whether it includes physical exercise or heart-stressing medicines.

• Exercise Stress Test: Some exercise on a treadmill or stationary cycle to improve blood flow to the heart and achieve a specific heart rate.

• Pharmacologic Stress Test: If people cannot exercise, they are given medicine to enhance blood flow and strain the heart.

Conclusion

Nuclear cardiology has been one of the most common nuclear medicine practices for many years. Recent advances in CT and MR radiologic examinations have presented a significant challenge to nuclear cardiology. Radiation exposure is another issue with myocardial perfusion SPECT. However, considerable progress has been made in nuclear cardiology in terms of software and hardware. Furthermore, the development of new radiopharmaceuticals will surely benefit nuclear cardiology. As a result, nuclear cardiology remains one of the most promising topics in nuclear medicine.